We welcome the independent Assessment of the Results and Accountability Framework of UBRAF. It raises a number of important issues with regard to efficacy of the framework including inadequacy of the indicators in measuring country level coordination and collaboration, a lack of consistent approach, and an overly complex matrix with too many indicators.
We support the recommendation that the UBRAF be simplified and streamlined and that the number of indicators be reduced, but in keeping with the recommendation that the quality of the indicators be improved, with clear baselines and targets, that they be Specific, measurable, attainable, relevant and time-bound, and that they meet the MERG’s indicator standards.
The NGO delegation has committed to engage with the Secretariat in a process to develop CS indicators that are more meaningful. We wish to thank the Secretariat for its collaboration with us in this effort.
We are actively participating in the MERG Indicator Working Group. We urge that all bodies work within that framework and respect the work of the IWG as they consider and develop indicators so that we ensure that going forward indicators meeting internationally-agreed standards and so that the indicators being used by the various global bodies are truly harmonized.
Finally, we are concerned that, thirty years into the HIV epidemic, children continue to be left behind in the HIV response. While 58 percent of adults in need currently access treatment, only 28 percent of children living with HIV in need of treatment are accessing it. The need to take action on identifying and enrolling children in ART will be even more apparent after the new WHO ARV Guidelines are released in June recommending that all children infected with HIV below five years of age should be initiated on ART, regardless of WHO clinical stage or CD4 count. Currently, the barriers to increasing the number of children on ART are not being addressed sufficiently at the global or national level. These include social barriers, weak health systems, limited capacity of health care workers and lack of available child-friendly formulations. We urge UNAIDS and states to prioritize this concern, particularly in light of the special challenges children face in accessing treatment and the huge disparity in treatment rates. And, in that same vein, we cannot help but underscore the need to collect data on those aging with HIV so that we can develop more targeted responses to their particular circumstances.